The Team

Dr Leearne Hinch

Chief Executive Officer

Dr Leearne Hinch BSc BVMS MBA is an experienced biotechnology executive and life sciences commercialisation consultant. Leearne has a strong track record in company leadership, business strategy, fundraising, sales, business development and technology commercialisation. She has held senior executive, management and consulting positions in ASX-listed biotechnology, multinational and private companies where she led the development and commercialisation of multiple diagnostic, device, therapeutic and animal health products. Leearne holds Bachelor of Science, Bachelor of Veterinary Medicine and Surgery, and a Master of Business Administration.

Dr Gregory Rice

Chief Scientific Officer

Dr Greg Rice PhD BSc (Hon) MHA Grad Dip Mgt is an internationally recognised academic and commercial scientist with over 30 years’ expertise and experience in oncology, perinatology, exosome-based research, clinical translational research, IVD development and commercialisation. He has held senior academic appointments, co-founded hospital-based clinical research centres in both oncology and perinatology, and co-founded and led diagnostic companies. He is an award-winning scientist with a strong international profile and clinical research networks. He has published more than 280 peer-reviewed scientific publications and is a regular invited speaker at international conferences. He has held numerous academic leadership positions including at the University of Queensland (UQ), Baker Heart and Diabetes Institute, University of Melbourne, and Monash University. As Director of the UQ Centre for Clinical Diagnostics (CCD), he established the Centre, implemented an ISO17025 quality management system, secured NATA accreditation, and established an exosome research facility to evaluate the clinical utility of extracellular vesicles as liquid biopsies, IVDs and therapeutics. Additionally, he was a Founding Director and CSO of diagnostics company HealthLinx Ltd and more recently CEO of Pregnostica SpA. His academic qualifications include a Doctor of Philosophy and Bachelor of Science (First Class Honours) from the University of Western Australia and a Graduate Diploma in Management and Master of Health Administration from RMIT University.

Mark Edwards

Chief Financial Officer & Company Secretary

Mark Edwards B.Acc., CA is a highly experienced CFO and Company Secretary with expertise in financial leadership and management, corporate governance, investor relations and corporate transactions. Most recently he was CFO and Company Secretary at Medical Developments International Ltd (ASX: MVP) for 8 years, where he managed over $60 million in capital raisings, relocated the head office and manufacturing facility, established global infrastructure and operations.

Dr Rocco Iannello

Business Development and Licensing Director

Dr Rocco Iannello BSc PhD MBA is a business development professional and research scientist with senior-level experience in IP commercialisation, business development and licensing across medical devices and pharmaceuticals.

He has held senior technology commercialisation roles in Academia and Industry, has been involved in the spin-out of a number of companies and led several significant commercial deals. He has strong Australian and international networks across government, academia, industry and venture capital.